August 11, 2008
Systems Analytics Provides RAMP Software Package to U.S. Food and Drug Administration
Waltham, MA, August 11, 2008 – Systems Analytics, a leading provider of high-throughput biomedical data analysis tools for the pharmaceutical and life sciences industrials, today announced that the U.S. Food and Drug Administration had licensed the company’s RAMP software package for MAQC-II applications.
RAMP (Robust Accurate Modeling Protocol) is a predictive model construction package developed by the company. It is a software product for optimal and automatic construction of accurate, reproducible and robust models for the prediction of clinically relevant outcomes using microarray gene expression data.
The MicroArray Quality Control (MAQC) consortium began in February 2005 with the goal of addressing various microarray reliability concerns pertaining to reproducibility of gene signatures, as part of the United States Food and Drug Administration’s Critical Path Initiative to medical product development. MAQC-II has focused on the evaluation of construction procedures of predictive models for their application to blind (future) datasets, which is one of the most important goals in using microarray data in the context of diagnostic, prognostic and predictive gene expression signature and product development.
Financial terms of the license were not released.
About Systems Analytics
Systems Analytics is a bioinformatics company dedicated to facilitating the discovery and evaluation of biomarkers of clinical, diagnostic and scientific significance. The company focuses on developing robust computational algorithms for achieving accurate, reliable and reproducible data analysis results. These algorithms are being used in genomics, proteomics and metabolic profiling studies where innovative and robust tools are required to extract useful practical knowledge from high-throughput datasets.